The United Kingdom has given temporary approval to the Pfizer-BioNTech vaccine for 12-15-year-olds after the government body that assesses medicines said it had “carefully reviewed clinical trial data” in this new age group.
Britain’s Medicines and Healthcare products Regulatory Agency (MHRA) has concluded the Pfizer/BioNTech COVID-19 vaccine is “safe and effective” for older children, it said as it issued a regulatory approval of the drug on Friday. The move leaves the door open for a vaccination campaign for British schoolchildren, the Guardian newspaper reported on Friday.
Children and adults over 16 were already approved for the Pfizer shot.
On the efficacy of the shot and the study preceding its approval, it was said: “Over 2000 children aged 12-15 years were studied as part of the randomised, placebo-controlled clinical trials. There were no cases of COVID-19 from 7 days after the second dose in the vaccinated group, compared with 16 cases in the placebo group.